NEW DELHI: After ICMR’s rejection of Chinese rapid test kits, China on Tuesday said it was unfair and irresponsible for “certain individuals” to label Chinese products as faulty and look at issues with “preemptive prejudice”.Recalling statements by the manufacturers that the kits had been validated and approved by ICMR, the embassy here expressed hope that India will respect China’s “goodwill and sincerity” and strengthen communication with relevant Chinese companies “based on facts” to resolve the issue “reasonably”.The controversy over the kits comes hard on the heels of the investment row which saw the government tweaking rules to ensure Chinese FDI into India came through the approval route at a time when many Indian firms seemed vulnerable to hostile takeovers. Chi na had then too strongly objected to the move.However, as the government had said last week, India continues to procure more and more medical equipment from China. The embassy said it attached great importance to the quality of its medical exports and the same kits had been “well recognised” in Europe, Asia and Latin America . ICMR carried out tests using the kits after some states reported that the apparatus was giving divergent results.ICMR concluded that the variations were too large and asked states to return the kits to be sent back to the Chinese firms. The Indian government said no money had been paid for the kits. “We have also learned that there are strict requirements for the storage, transportation and use of Covid-19 antibody rapid test kits. Any operation which is not carried out by professionals in accordance with the product specifications will lead to testing accuracy variations. ICMR also made it clear that rapid antibody test kits should only be used for surveillance purposes,” the embassy spokesperson said.